The hospice mergers & acquisition market has been at an all-time high for the past 18-24 months, but some sellers seem to enjoy a higher valuation than others. Why? There are many reasons, beyond just size, why some agencies are worth more in the eyes of a buyer.
Time and again, digital health entrepreneurs find themselves at a crossroads in their evolution. A period where, just when they have iterated and tweaked their product to the point that they have a proven solution, they run out of money to ramp up marketing and implementations.
With the unknown changes in reimbursement starting in 2020 from the Patient-Driven Groupings Model, buyers are showing caution when it comes to home health acquisitions.
Pharmacy services mergers and acquisitions – an M&A market that continues to garner interest from a broad base of strategic and financial buyers, yet struggles to find any measure of consistency.
Due to a saturated market and struggles with payment pressures, private equity companies are seeking to sell their urgent care platforms, which may be difficult with the number of buyers decreasing.
Happens all the time. As you iterate your initial idea into a viable revenue-generating product, your cash reserves begin to reflect the extended timeline. You need a quick hit.
There is a wave of private equity investment that is sweeping the Autism and ABA services industry across the nation, especially over the last two years. Dexter Braff spoke with Sr Plus, explaining what private equity is and how the field is rapidly changing as a result.
A large number of hospitals and health systems are expanding their home health businesses through partnering or acquiring home health agencies. From 2016 to 2018, 177 of these hospitals or health systems acquired home health care companies.
Director of Finance Steve Garbon is speaking as a panelist at the University of Pittsburgh's Private Equity and Venture Capital Club on Sunday, April 14.
MsRx, a specialty pharmacy located in Atlanta Georgia, was acquired by Encompass Rx, a division of CVS Health, a publicly traded diversified healthcare company. MsRx has a focus on serving patients with Multiple Sclerosis. The transaction enhances the existing CVS pharmacy business in Georgia and surrounding states.
